/PRNewswire/ The "Prosthetic joint infections - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com s offering. This report.
By Chris Wack Aridis Pharmaceuticals shares were up 33% to 36 cents after the company said the Food and Drug Administration has granted Qualified Infectious.
By Chris Wack Aridis Pharmaceuticals said Wednesday that the U.S. Food and Drug Administration has granted Qualified Infectious Disease Product Designation.
Eagle Pharmaceuticals, Inc. (EGRX) announced the FDA has granted Qualified Infectious Disease Product Designation and Fast Track Designation for CAL02, a non-biological bacterial virulence neutralizer, anti-infective agent being developed to treat severe community-acquired bacterial pneumonia as an add-on therapy to standard of care.